age at least 18 Years
Item
age at least 18 Years
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Multiple Myeloma
Item
Multiple Myeloma
boolean
C0026764 (UMLS CUI 2011AA)
Documented progression from most recent line of therapy
Item
Documented progression from most recent line of therapy
boolean
C1301725 (UMLS CUI 2011AA)
397934002 (SNOMED CT 2011_0131)
C0449258 (UMLS CUI 2011AA)
246450006 (SNOMED CT 2011_0131)
C1513491 (UMLS CUI 2011AA)
RECENT (HL7 V3 2006_05)
CL415196 (UMLS CUI 2011AA)
C0039798 (UMLS CUI 2011AA)
1 - 3 prior lines of therapy
Item
1 - 3 prior lines of therapy
boolean
CL415096 (UMLS CUI 2011AA)
C0205449 (UMLS CUI 2011AA)
421291004 (SNOMED CT 2011_0131)
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
CL415196 (UMLS CUI 2011AA)
C0039798 (UMLS CUI 2011AA)
Measurable disease
Item
Measurable Disease
boolean
C1513041 (UMLS CUI 2011AA)
Life expectancy >=3 months
Item
Life expectancy >=3 months
boolean
C0023671 (UMLS CUI 2011AA)
Prior treatment with Lenalidomide permitted if:
Item
Prior treatment with Lenalidomide permitted if:
boolean
C1514463 (UMLS CUI 2011AA)
C1144149 (UMLS CUI 2011AA)
421471009 (SNOMED CT 2011_0131)
C0521104 (UMLS CUI 2011AA)
75554001 (SNOMED CT 2011_0131)
C0750557 (UMLS CUI 2011AA)
Best response achieved was ≥ Partial Response (PR)
Item
Best response achieved was ≥ Partial Response (PR)
boolean
C2986560 (UMLS CUI 2011AA)
C0680378 (UMLS CUI 2011AA)
C0439091 (UMLS CUI 2011AA)
276138003 (SNOMED CT 2011_0131)
GE (HL7 V3 2006_05)
C1521726 (UMLS CUI 2011AA)
103337004 (SNOMED CT 2011_0131)
Patient was not refractory
Item
Patient was not refractory
boolean
C1518422 (UMLS CUI 2011AA)
C0205269 (UMLS CUI 2011AA)
20646008 (SNOMED CT 2011_0131)
Patient did not discontinue due to a Grade ≥ 3 related adverse event
Item
Patient did not discontinue due to a Grade ≥ 3 related adverse event
boolean
C1518422 (UMLS CUI 2011AA)
C0457454 (UMLS CUI 2011AA)
278308006 (SNOMED CT 2011_0131)
CL420107 (UMLS CUI 2011AA)
C1519275 (UMLS CUI 2011AA)
CL427997 (UMLS CUI 2011AA)
C1705232 (UMLS CUI 2011AA)
Subject did not receive > 9 cycles of Lenalidomide and had at least 9 months between the last dose of Lenalidomide and progression
Item
Subject did not receive > 9 cycles of Lenalidomide and had at least 9 months between the last dose of Lenalidomide and progression
boolean
C1518422 (UMLS CUI 2011AA)
C1514756 (UMLS CUI 2011AA)
C0439093 (UMLS CUI 2011AA)
276140008 (SNOMED CT 2011_0131)
GT (HL7 V3 2006_05)
C0205455 (UMLS CUI 2011AA)
422113007, 36987007 (SNOMED CT 2011_0131)
C0439596 (UMLS CUI 2011AA)
44180009 (SNOMED CT 2011_0131)
C1144149 (UMLS CUI 2011AA)
421471009 (SNOMED CT 2011_0131)
Subjects with non-secretory or oligo-secretory or free light-chain only myeloma
Item
Subjects with non-secretory or oligo-secretory or free light-chain only myeloma
boolean
C0456845 (UMLS CUI 2011AA)
277580004 (SNOMED CT 2011_0131)
10029662 (MedDRA 14.1)
C0205251 (UMLS CUI 2011AA)
62482003 (SNOMED CT 2011_0131)
C0036536 (UMLS CUI 2011AA)
CL324441 (UMLS CUI 2011AA)
C0332296 (UMLS CUI 2011AA)
37837009 (SNOMED CT 2011_0131)
C0456844 (UMLS CUI 2011AA)
277579002 (SNOMED CT 2011_0131)
Active plasma cell leukemia
Item
Active plasma cell leukemia
boolean
C0205177 (UMLS CUI 2011AA)
55561003 (SNOMED CT 2011_0131)
C0023484 (UMLS CUI 2011AA)
95210003 (SNOMED CT 2011_0131)
10035222 (MedDRA 14.1)
C90.1 (ICD-10-CM Version 2010)
203.1 (ICD-9-CM Version 2011)
Positive for Hepatitis B, C or Human Immunodeficiency Virus (HIV)
Item
Positive for Hepatitis B, C or Human Immunodeficiency Virus (HIV)
boolean
C0856706 (UMLS CUI 2011AA)
10019738 (MedDRA 14.1)
C1112419 (UMLS CUI 2011AA)
10057394 (MedDRA 14.1)
C0019699 (UMLS CUI 2011AA)
165816005 (SNOMED CT 2011_0131)
10020188 (MedDRA 14.1)
Z21 (ICD-10-CM Version 2010)